Brazil withdraws spinal implant
This article was originally published in Clinica
Brazilian healthcare surveillance agency Anvisa has withdrawn from use and suspended the manufacture, distribution and commercialisation of a vertebral implant manufactured by Equimed - Industria de Equipamentos Medicos. The action was taken against the Porto Alegre, Rio Grande do Sul firm for its failure to register the Placa Conjugada Cervical device with Anvisa, said the agency.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.